Page 9 - Indian Pharma Companies

Health Minister inaugurates India's first pneumococcal conjugate vaccine

Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India

We are researching two candidates for Covid vaccines: Serum Institute CEO

In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity

Pharma revenue, margins likely to remain healthy in next fiscal: ICRA

Revenue growth for IPM (Indian Pharmaceutical Market) is expected to be 7-9 per cent in FY2021 despite muted growth in Q1 FY2021

Vial, syringe makers push the pedal as Covid-19 vaccine roll-out nears

Most firms plan to increase capacity to meet fresh orders

Shelf life of vaccines likely to be more than 3 months, unlike drugs

They have the stability data for these investigational products, said a source

India's first mRNA Covid-19 vaccine gets nod to start phase 1 trials

The Central Drugs Standard Control Organisation permitted Pune-based Gennova Biopharmaceuticals to conduct Phase 1/2 clinical trials for its mRNA Covid-19 vaccine candidate

The next online tonic: E-majors, corporate giants eye e-pharmacy business

Amazon, Reliance recently announced their foray into e-pharma sector

Aurobindo Pharma completes sale of US subsidiary's Natrol to New Mountain

Drug firm Aurobindo Pharma said it has completed the sale of Natrol LLC, a wholly-owned unit of its US-based subsidiary, to private equity firm New Mountain Capital

Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May

Aurobindo Pharma expects to commercialise its Covid-19 vaccine manufacturing facility in Hyderabad by April-May next year, according to a top company official

Indian pharma has bounced back from lockdown lows. What led to turnaround?

From the lows of the lockdown, the industry has seen a robust bounceback

Serum Institute, Bharat Biotech gear up to export Covid-19 vaccine shots

Serum, Bharat Biotech in talks with countries, agencies to supply vaccines

Biological E's Covid-19 vaccine enters Phase I/II trial after DGCI nod

The results of this clinical trial are expected to be available by February 2021, the release said.

PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma

The incentive will be in the range of 5-10 per cent of production value, sources said.

US presidential election results may not impact Indian pharma industry

Europe, not India, will be the 1st target if US reduces import dependence: Experts

Covid-19 antigen testing: India next stop for Siemens Healthineers

The investment is part of Siemens Healthineers' strategy 2025, in which India plays an important role as a growth market for the firm.

Covid-19 crisis: India may mobilise pharmacists to administer vaccine

30 million health care workers ready for first phase in January

Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Suresh Jadhav, executive director of the Serum Institute of India (SII), said the biotechnology company has already put in place an expansion plan for new products in the pipeline

Paracetamol curbs amid Covid-19 pandemic dent sales during monsoon

Sales of paracetamol are typically high during monsoon when cold and flu ailments are common

How India is gearing up its cold chain for Covid-19 vaccine distribution

The expert committee on vaccine administration has initiated talks on cold chain logistics and models that may be required to be adopted

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment